TRV GP II’s Allena Pharmaceuticals ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,790,964
| Closed | -$533K | – | 2 |
|
|
2022
Q2 | $533K | Hold |
2,790,964
| – | – | 11.54% | 2 |
|
|
2022
Q1 | $645K | Hold |
2,790,964
| – | – | 6.58% | 2 |
|
|
2021
Q4 | $1.65M | Hold |
2,790,964
| – | – | 6.84% | 2 |
|
|
2021
Q3 | $2.52M | Hold |
2,790,964
| – | – | 11.16% | 2 |
|
|
2021
Q2 | $3.63M | Hold |
2,790,964
| – | – | 10.71% | 2 |
|
|
2021
Q1 | $3.88M | Hold |
2,790,964
| – | – | 2.45% | 3 |
|
|
2020
Q4 | $3.57M | Hold |
2,790,964
| – | – | 2.49% | 3 |
|
|
2020
Q3 | $4.13M | Hold |
2,790,964
| – | – | 2.68% | 3 |
|
|
2020
Q2 | $4.41M | Hold |
2,790,964
| – | – | 3.26% | 3 |
|
|
2020
Q1 | $2.69M | Hold |
2,790,964
| – | – | 2.89% | 3 |
|
|
2019
Q4 | $7.62M | Hold |
2,790,964
| – | – | 7.86% | 2 |
|
|
2019
Q3 | $11M | Hold |
2,790,964
| – | – | 24.4% | 2 |
|
|
2019
Q2 | $11.4M | Hold |
2,790,964
| – | – | 18.32% | 2 |
|
|
2019
Q1 | $19.6M | Hold |
2,790,964
| – | – | 12.77% | 3 |
|
|
2018
Q4 | $15.2M | Hold |
2,790,964
| – | – | 15.11% | 3 |
|
|
2018
Q3 | $30M | Hold |
2,790,964
| – | – | 17.6% | 3 |
|
|
2018
Q2 | $36.4M | Hold |
2,790,964
| – | – | 20.62% | 3 |
|
|
2018
Q1 | $30.8M | Hold |
2,790,964
| – | – | 5.76% | 4 |
|
|
2017
Q4 | $28.1M | Buy |
+2,790,964
| New | +$34.4M | 5.06% | 5 |
|
Other funds holding ALNA
TRV GP II's ALNA Position: Q3 2022 in Review
TRV GP II sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 2,790,964 shares — an estimated $533K sold.
TRV GP II first reported a position in ALNA in Q4 2017 and held it in 19 quarters. The position peaked at $36.4M in Q2 2018. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.
- TRV GP II reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- TRV GP II sold 2,790,964 Allena Pharmaceuticals shares in Q3 2022, an estimated $533K.
- TRV GP II first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 19 quarters.
- TRV GP II's Allena Pharmaceuticals position peaked at $36.4M in Q2 2018.
- 2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.
Based on TRV GP II's 13F filing for Q3 2022, filed 3 Nov 2022.